Table 1:
Summary of drug uptake transporters involved in protein-protein interaction
| Transporter | Interaction Partner | Functional Change?* | Expression Change?* |
|---|---|---|---|
| NTCP | NTCP | No | N/A |
| SOAT | ↓ | ↓ | |
| OATP1B1 | OATP1B1 | ↓ | ↓ |
| OATP1B3 | OATP1B3 | No | No |
| OATP1B1 | N/A | N/A | |
| NTCP | N/A | N/A | |
| OSTα | OSTβ | Required for function | Required for membrane expression |
| OCT1 | OCT1 | No | N/A |
| OCT2 | OCT2 | N/A | N/A |
| LAPTM4A | N/A | N/A | |
| CD63 | N/A | N/A | |
| OAT1 | OAT1 | ↓ | ↓ |
| OAT3 | OAT3 | N/A | N/A |
| Caveolin-1 | ↑ due to gain of protein-cytoskeletal interaction | Redistribution to non-LRD-rich compartments | |
| β-actin | |||
| Myosin | |||
| OCTN2 | Caveolin-1 | N/A | N/A |
| Flotillin | N/A | N/A |
Functional and expression change means that the potential changes happened to the target transporter by the interactions with the partner transporters. Arrows represent the increase (↑) or decrease (↓) of function or membrane expression.